biosci2023unige

Publisher

Bioscientifica / Society for Endocrinology Group of Companies

Agreement ID biosci2023unige
Agreement labeling Read & Publish Licence
Has the agreement been disclosed and published? No
Agreement period 01/01/2023 – 12/31/2023
Consortia / Institution Université de Genève
Country Switzerland
SIZE

Approximate range of annual corresponding author publications

1
COSTS

How do the costs of the agreement relate to previous subscription-only agreements with the publisher?

Cost increase
Comments on cost development Cost increase covered as soon as 1 article is published
FINANCIAL SHIFT

Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?

 

No subdivision between publishing fee and subscription fee
RISK SHARING

How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?

Shared risks: unlimited quota for publishing but no reimbursement if no eligible article published
OA COVERAGE

Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?

No
Are fully open access journals covered by the agreement? No
OA LICENSE CC-BY mandatory
ARTICLE TYPES
Original research articles
Review articles
Proceedings
Letters
Editorials
All article types
ACCESS COSTS

What is the approximate share of access related costs of the overall agreement?

More than 50%
Comments on access costs 90% Access, 10% Publish
ACCESS COVERAGE

Are all read relevant journals covered by the agreement?

Yes
PERPETUAL ACCESS RIGHTS Yes
WORKFLOW ASSESSMENT Ok
Comments on workflows Through CCC Rightslink
Request contact to the licensee contact@esac-initiative.org